Table 1 Basic characteristics of selected patients
Indexes | control (n = 98) | HP (n = 67) | CVVH (n = 59) | SHP (n = 135) | SHP + CVVH (n = 128) | P |
|---|---|---|---|---|---|---|
Age (years) | 35.88 ± 15.77 | 38.93 ± 14.34 | 32.41 ± 16.02 | 33.27 ± 13.03 | 35.97 ± 14.08 | 0.61 |
Male, n (%) | 43(43.88%) | 27(40.30%) | 25(42.37%) | 56(41.48%) | 54(42.19%) | 0.993 |
Body mass index | 23.07 ± 4.10 | 22.31 ± 5.22 | 24.13 ± 3.30 | 23.94 ± 4.07 | 22.01 ± 5.44 | 0.39 |
Number of people with oral poisoning, n (%) | 89(90.82) | 61(91.04) | 53(89.83) | 113(91.11) | 117(91.41) | 0.263 |
Time from poisoning to treatment (h) | 7.03 ± 3.47 | 6.54 ± 4.05 | 7.19 ± 3.71 | 6.35 ± 3.09 | 6.73 ± 3.41 | 0.17 |
Time from poisoning to gastric lavage (h) | 4.49 ± 1.31 | 4.08 ± 1.72 | 4.45 ± 1.14 | 4.37 ± 1.38 | 4.19 ± 1.49 | 0.871 |
Time from poisoning to hemoperfusion (h) | 9.12 ± 2.36 | 8.96 ± 2.59 | 9.02 ± 2.75 | 0.89 | ||
Acute kidney injury, n (%) | 26(26.53%) | 15(22.39%) | 14(23.73%) | 32(23.37%) | 35(27.34%) | 0.923 |
BUN(mmol/L) | 7.33 ± 5.08 | 7.21 ± 5.14 | 7.47 ± 4.89 | 7.41 ± 4.73 | 7.50 ± 4.55 | 0.94 |
CREA (μmol/L) | 129.00 ± 98.52 | 127.91 ± 91.55 | 133.04 ± 87.05 | 136.34 ± 90.34 | 134.51 ± 92.74 | 0.77 |
AST (IU/L) | 79.04 ± 52.8 | 78.13 ± 61.77 | 79.26 ± 50.41 | 77.45 ± 54.73 | 78.24 ± 57.49 | 0.59 |
ALT (IU/L) | 90.74 ± 57.82 | 88.30 ± 61.37 | 91.04 ± 53.33 | 88.21 ± 60.32 | 89.36 ± 55.82 | 0.74 |
Respiratory failure, n(%) | 13(13.27%) | 7(10.45%) | 6(10.17%) | 19(14.07) | 21(16.41%) | 0.726 |
Arterial blood gas analysis | ||||||
PH | 7.38 ± 0.14 | 7.31 ± 0.17 | 7.40 ± 0.11 | 7.35 ± 0.18 | 7.42 ± 0.17 | 0.83 |
PO2 (mmHg) | 84.05 ± 19.44 | 83.42 ± 18.79 | 83.14 ± 16.94 | 85.74 ± 17.03 | 83.97 ± 17.28 | 0.74 |
PCO2 (mmHg) | 26.63 ± 11.05 | 26.08 ± 12.07 | 29.15 ± 10.85 | 27.46 ± 11.33 | 27.04 ± 13.01 | 0.80 |